SINO BIOPHARM(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01177 SINO BIOPHARM

Not Yet Opened 01-30 16:08:04

6.640

-0.230

-3.35%

High6.890	Low6.610	Vol85.00M
Open6.870	D1 Closing6.870	Amplitude4.08%
Mkt Cap124.57B	Tradable Cap124.57B	Total Shares18.76B
T/O568.93M	T/O Rate0.45%	Tradable Shares18.76B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"SINO BIOPHARM","latestPrice":6.64,"timestamp":1769760484005,"preClose":6.87,"halted":0,"volume":85002323,"delay":0,"changeRate":-0.033478893740902536,"floatShares":18761000000,"shares":18761000000,"eps":0.21479705469445792,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"01-30 16:08:04","open":6.87,"high":6.89,"low":6.61,"amount":568927401,"amplitude":0.040757,"askPrice":6.64,"askSize":1276000,"bidPrice":6.63,"bidSize":71000,"shortable":3,"etf":0,"ttmEps":0.2400733063858377,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":6.87,"dividendRate":0.013811,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":1.3639407051954717,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.1639,"impliedVolPercentile":0.0282},"requestUrl":"/m/hq/s/01177","defaultTab":"news","newsList":[{"id":"2607609723","title":"Sino Biopharmaceutical Stock Falls 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2607609723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607609723?lang=en_us&edition=fundamental","pubTime":"2026-01-30 16:32","pubTimestamp":1769761920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 3.3% to 6.64 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 2.1% to 27387.11.The stock's fall snapped a three-day winning streak.Sino Biopharmaceutical Ltd. closed 27% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 10% and Amgen Inc. remained unchanged.Trading volume totaled 85.0 million shares, compared to the 50-day average of 62.5 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","HK0000165453.HKD","BK1515","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1521","01177","BK1191"],"gpt_icon":0},{"id":"2606795774","title":"Sino Biopharmaceutical Stock Climbs 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2606795774","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606795774?lang=en_us&edition=fundamental","pubTime":"2026-01-28 16:33","pubTimestamp":1769589180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 2.4% to 6.83 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 2.6% to 27826.91.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 25% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 6.1% and Amgen Inc. remained unchanged.Trading volume totaled 90.0 million shares, compared to the 50-day average of 62.7 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1589","BK1521","BK1191","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01177","HK0000165453.HKD","BK1515"],"gpt_icon":0},{"id":"2606734204","title":"Sino Biopharmaceutical Hepatitis B Drug Meets Primary Goal of Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2606734204","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606734204?lang=en_us&edition=fundamental","pubTime":"2026-01-27 17:04","pubTimestamp":1769504671,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  said a mid-stage trial of its TQA3605 tablets for the treatment of hepatitis B met its primary goal, according to a Hong Kong bourse filing Tuesday.Results showed the medicine, when combined with antiviral drugs known as nucleoside analogues, helped kept the disease at bay.Specifically, after 24 weeks of treatment, HBV-infected adults who received the company's medicine achieved HBV DNA levels below the lower limit of quantification when compared to nucleoside analogues alone.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","HK0000165453.HKD","IE00BZ08YS42.EUR","01177","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1191","BK1589","BK1521"],"gpt_icon":0},{"id":"1190743665","title":"Sino Biopharmaceutical Limited (1177) Announces Positive Phase II Results for TQA3605 \"Core Protein Allosteric Modulator\" in Chronic Hepatitis B","url":"https://stock-news.laohu8.com/highlight/detail?id=1190743665","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190743665?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:45","pubTimestamp":1769503510,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited (1177) recently reported that its independently developed Class I innovative drug, TQA3605 tablets—known as a Core Protein Allosteric Modulator (CpAM)—has successfully...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"gpt_icon":0},{"id":"2606013432","title":"Sino Biopharmaceutical Reports Positive Phase II Results for Hepatitis B Drug TQA3605","url":"https://stock-news.laohu8.com/highlight/detail?id=2606013432","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606013432?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:31","pubTimestamp":1769502661,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited announced positive results from a Phase II clinical trial of TQA3605, a core protein allosteric modulator  for the treatment of chronic hepatitis B. The randomized, double-blind, placebo-controlled, multi-center study evaluated the efficacy and safety of TQA3605 in combination with nucleoside analogues  in patients with chronic HBV infection and low-level viremia. A total of 122 subjects were enrolled, and the results showed that all TQA3605 dose groups achieved approximately 90% of subjects with HBV DNA levels below the lower limit of quantification , significantly surpassing the NAs monotherapy control group. The safety profile of TQA3605 was generally favorable, with most adverse events reported as Grade 1 to 2 and comparable incidence rates to the control group. The company stated that detailed results from the study will be presented at upcoming international academic conferences.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL98b53s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","BK1191","BK1515","HK0000165453.HKD","BK1521","BK1589","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2606218549","title":"Sino Biopharmaceutical Stock Slides 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2606218549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606218549?lang=en_us&edition=fundamental","pubTime":"2026-01-26 16:33","pubTimestamp":1769416380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.7% to 6.52 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 26765.52.Sino Biopharmaceutical Ltd. closed 29% below its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 2.1% and Amgen Inc. remained unchanged.Trading volume totaled 45.7 million shares, compared to the 50-day average of 65.2 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1515","BK1521","BK1191","IE00BZ08YT58.USD","BK1589","01177"],"gpt_icon":0},{"id":"2605420645","title":"Sino Biopharmaceutical Stock Advances 2.0% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2605420645","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605420645?lang=en_us&edition=fundamental","pubTime":"2026-01-23 16:32","pubTimestamp":1769157120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 2.0% to 6.63 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 26749.51.Sino Biopharmaceutical Ltd. closed 27% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.3% and Amgen Inc. remained unchanged.Trading volume totaled 58.2 million shares, compared to the 50-day average of 65.1 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589","01177","IE00BZ08YT58.USD","BK1191","BK1515","BK1521"],"gpt_icon":0},{"id":"2605174695","title":"Sino Biopharmaceutical Stock Rises 1.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2605174695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605174695?lang=en_us&edition=fundamental","pubTime":"2026-01-21 16:33","pubTimestamp":1768984380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 1.1% to 6.57 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 26585.06.The stock's rise snapped a four-day losing streak.Sino Biopharmaceutical Ltd. closed 28% below its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.6% and Amgen Inc. remained unchanged.Trading volume totaled 49.4 million shares, compared to the 50-day average of 66.0 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YR35.GBP","BK1521","BK1589","BK1191","HK0000165453.HKD","IE00BZ08YS42.EUR","01177","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2604189132","title":"Sino Biopharmaceutical Stock Slips 6.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2604189132","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604189132?lang=en_us&edition=fundamental","pubTime":"2026-01-19 16:31","pubTimestamp":1768811460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 6.2% to 6.52 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 26563.90.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 29% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.9% and Amgen Inc. remained unchanged.Trading volume totaled 87.1 million shares, compared to the 50-day average of 66.0 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","01177","BK1515","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1589","HK0000165453.HKD","BK1191","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"1104241795","title":"Citigroup: SINO BIOPHARM (01177) Acquisition of siRNA Firm Enhances Out-Licensing Potential; Sets Target Price at HK$10.8, \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1104241795","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104241795?lang=en_us&edition=fundamental","pubTime":"2026-01-16 09:18","pubTimestamp":1768526298,"startTime":"0","endTime":"0","summary":"Citigroup released a research report stating that SINO BIOPHARM (01177) announced the acquisition of Hygieia, a private biotech company specializing in small interfering RNA (siRNA) drugs, for a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU2236285917.USD","LU1162221912.USD","BK4588","LU2456880835.USD","LU0128525689.USD","BK1515","IE00BZ08YT58.USD","C","LU0648001328.SGD","LU2417539215.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","BK4534","LU0098860793.USD","BK1191","LU1244550494.USD","LU0162691827.USD","LU2360032135.SGD","LU2125154778.USD","LU1267930227.SGD","LU0072461881.USD","LU0106831901.USD","01177","LU0130102774.USD","LU0477156953.USD","LU0310800965.SGD","LU0170899867.USD","BK4566","IE00BSNM7G36.USD","LU1201861249.SGD","LU0980610538.SGD","BK4559","LU0130517989.USD","LU1244550221.USD","BK4504","BK4585","BK4207","BK1521","LU2462157665.USD","IE00BZ08YR35.GBP","LU1791807156.HKD","LU1244550577.SGD","LU1668664300.SGD","LU0052756011.USD","LU2125154935.USD","LU1366192091.USD","LU0320765646.SGD"],"gpt_icon":0},{"id":"1195281347","title":"CICC Maintains \"Outperform\" Rating on Sino Biopharm (01177) with HK$8.9 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1195281347","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195281347?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:36","pubTimestamp":1768466192,"startTime":"0","endTime":"0","summary":"CICC has released a research report reiterating its HK$8.9 target price and \"Outperform\" rating for Sino Biopharm (01177). The firm has kept its adjusted net profit forecasts for 2025 and 2026...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1515","IE00BZ08YT58.USD","BK1191","BK1589","BK1521","01177"],"gpt_icon":0},{"id":"2603677918","title":"Sino Biopharmaceutical Stock Slides 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2603677918","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603677918?lang=en_us&edition=fundamental","pubTime":"2026-01-15 16:33","pubTimestamp":1768465980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.5% to 7.00 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 26923.62.The stock's fall snapped a four-day winning streak.Sino Biopharmaceutical Ltd. closed 23% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 46.3 million shares, compared to the 50-day average of 68.4 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","HK0000165453.HKD","IE00BZ08YT58.USD","BK1515","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","01177","BK1191","BK1521"],"gpt_icon":0},{"id":"2603869567","title":"Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2603869567","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603869567?lang=en_us&edition=fundamental","pubTime":"2026-01-14 16:32","pubTimestamp":1768379520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rose 2.9% to 7.11 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 26999.81.This was the stock's fourth consecutive day of gains.Sino Biopharmaceutical Ltd. closed 22% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 0.3% and Amgen Inc. remained unchanged.Trading volume totaled 151.5 million shares, compared to the 50-day average of 68.1 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","BK1515","BK1191","BK1521","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","01177","BK1589"],"gpt_icon":0},{"id":"2603660187","title":"Sino Biopharmaceutical (SEHK:1177) Is Up 5.0% After Advancing ROCK2 Drug TDI01 To Phase III - Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603660187","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603660187?lang=en_us&edition=fundamental","pubTime":"2026-01-14 12:45","pubTimestamp":1768365908,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical’s board previously reported enrollment of the first patient in a global first Phase III trial of TDI01, a highly selective ROCK2 inhibitor for idiopathic pulmonary fibrosis, following encouraging Phase II efficacy and safety data.\nThe same molecule has also entered Breakthrough Therapy Designation review in China for chronic graft-versus-host disease, underlining its potential relevance across multiple serious immune-related conditions.\nWe’ll now examine how advancing...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/sino-biopharmaceutical-sehk1177-is-up-50-after-advancing-roc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/sino-biopharmaceutical-sehk1177-is-up-50-after-advancing-roc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000165453.HKD","BK1515","BK4134","BK1191","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1589","III","01177","BK1521","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"1137484597","title":"China Biopharma Giant's Major Acquisition Sparks Broad Rally in Hong Kong Healthcare Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1137484597","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137484597?lang=en_us&edition=fundamental","pubTime":"2026-01-14 12:03","pubTimestamp":1768363407,"startTime":"0","endTime":"0","summary":"On the morning of January 14th, the Hang Seng Healthcare ETF (159892) and the Hong Kong Stock Connect Healthcare ETF (520510) surged by more than 3% at one point. AliHealth jumped over 11%, with...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"19a45d98d676f675f3dd1dad1f11fa69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","BK1191","BK1515","IE00BZ08YT58.USD","BK1521","01177","159718","IE00BZ08YS42.EUR","BK1589"],"gpt_icon":0},{"id":"1183437742","title":"Stock Track | SINO BIOPHARM Soars 5.21% Intraday on Acquisition of Hangzhou Hygieia Biomedical","url":"https://stock-news.laohu8.com/highlight/detail?id=1183437742","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183437742?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:36","pubTimestamp":1768354610,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM (01177.HK) saw its stock price surge by 5.21% during the intraday session on Wednesday. This significant movement follows the company's announcement of its acquisition of China-based...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01177"],"gpt_icon":0},{"id":"1186281688","title":"Hong Kong Stock Announcement Highlights | JD Logistics Plans to Voluntarily Withdraw Deppon Logistics' Listing on Shanghai Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1186281688","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186281688?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:10","pubTimestamp":1768317026,"startTime":"0","endTime":"0","summary":"Major Announcements: Shanghai Pharmaceuticals (02607): The marketing application for the active pharmaceutical ingredient Isavuconazole Sulfate has been approved. SINO BIOPHARM (01177) plans to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1594","BK0232","BK1538","BK1589","BK1151","BK1502","BK1541","BK1179","HK0000165453.HKD","01478","IE00BZ08YT58.USD","BK1604","BK1608","01898","01177","01274","BK1096","603056","01263","BK1504","BK1144","02618","BK1178","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1521","BK1587","BK1191","BK1193"],"gpt_icon":0},{"id":"2603688901","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688901","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688901?lang=en_us&edition=fundamental","pubTime":"2026-01-13 18:59","pubTimestamp":1768301979,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsJan 13 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Tuesday:** Hong Kong-listed Sino Biopharmaceutical <117","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL6N3YE0RN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1191","BK1515","01177","BK1521"],"gpt_icon":0},{"id":"2603050064","title":"Sino Biopharmaceutical buys drugmaker Hangzhou Hygieia Biomedical for up to $172 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2603050064","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603050064?lang=en_us&edition=fundamental","pubTime":"2026-01-13 18:24","pubTimestamp":1768299858,"startTime":"0","endTime":"0","summary":"Jan 13  - Hong Kong-listed Sino Biopharmaceutical 1177.HK said on Tuesday it would acquire China-based Hangzhou Hygieia Biomedical for up to 1.20 billion yuan , as it looks to bolster its portfolio of chronic-disease treatments.Sino Biopharmaceutical said a unit would buy a 100% stake in Hygieia, with the consideration to be paid partly in cash and partly in newly issued shares.Following completion, Hangzhou Hygieia will become a unit of Sino Biopharmaceutical, it added.The deal marks Sino Biopharmaceutical's latest acquisition,  as it expands its innovative drug pipeline, following last year's agreement to acquire  LaNova Medicines.Hygieia focuses on the development of small interfering RNA therapies and has built an end-to-end drug development platform from target discovery to clinical proof-of-concept.      Its research is focused on weight management and metabolism, cardiovascular and cerebrovascular diseases, and neurological disorders.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YE0QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK1515","IE00BZ08YT58.USD","BK1521","BK1191","HK0000165453.HKD","BK1589","IE00BZ08YS42.EUR","01177"],"gpt_icon":0},{"id":"1167402246","title":"SINO BIOPHARM (01177) Appoints Lai Juan as Company Secretary and Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1167402246","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167402246?lang=en_us&edition=fundamental","pubTime":"2026-01-13 18:07","pubTimestamp":1768298844,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM (01177) announced that effective January 13, 2026, the following changes will take effect: 1. Mr. Chen Kainian has resigned from his position as Company Secretary and will no longer...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01177","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1521","HK0000165453.HKD","BK1589","IE00BZ08YT58.USD","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.0015},{"period":"1month","weight":0.0744},{"period":"3month","weight":-0.0608},{"period":"6month","weight":-0.087},{"period":"1year","weight":1.3868},{"period":"ytd","weight":0.0744}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.008254},{"month":2,"riseRate":0.681818,"avgChangeRate":0.063302},{"month":3,"riseRate":0.590909,"avgChangeRate":0.048254},{"month":4,"riseRate":0.5,"avgChangeRate":0.025891},{"month":5,"riseRate":0.727273,"avgChangeRate":0.043347},{"month":6,"riseRate":0.363636,"avgChangeRate":0.00957},{"month":7,"riseRate":0.636364,"avgChangeRate":0.047691},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.010062},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.015174},{"month":10,"riseRate":0.545455,"avgChangeRate":0.025184},{"month":11,"riseRate":0.5,"avgChangeRate":0.066781},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.01175}],"exchange":"SEHK","name":"SINO BIOPHARM","nameEN":"SINO BIOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINO BIOPHARM(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINO BIOPHARM(01177) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINO BIOPHARM,01177,SINO BIOPHARM股票,SINO BIOPHARM股票老虎,SINO BIOPHARM股票老虎国际,SINO BIOPHARM行情,SINO BIOPHARM股票行情,SINO BIOPHARM股价,SINO BIOPHARM股市,SINO BIOPHARM股票价格,SINO BIOPHARM股票交易,SINO BIOPHARM股票购买,SINO BIOPHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINO BIOPHARM(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINO BIOPHARM(01177) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}